Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Leuk Lymphoma. 2017 Jul 18;59(3):695–701. doi: 10.1080/10428194.2017.1347930

Table 3.

Performance status (PS) disagreement for all leukemia and lymphoma survivors and the subtypes of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)

Overall
Disagreement
CLL/SLL
Disagreement
HL
Disagreement
NHL
Disagreement
N (%) p-value N (%) p-value N (%) p-value N (%) p-value




Age 0.001 Age 0.014 Age 0.65 Age 0.004
 ≤ 60 609 (30%)  ≤ 60 103 (19%)  ≤ 60 103 (34%)  ≤ 60 403 (32%)
 > 60 660 (39%)  > 60 172 (32%)  > 60 24 (29%)  > 60 464 (42%)
Gender 0.37 Gender 0.78 Gender 0.11 Gender 0.37
 Female 529 (33%)  Female 93 (28%)  Female 55 (26%)  Female 381 (36%)
 Male 740 (36%)  Male 182 (26%)  Male 72 (39%)  Male 486 (39%)
Education 0.48 Education 0.58 Education 0.85 Education 0.61
High school or less 208 (36%) High school or less 54 (26%) High school or less 13 (23%) High school or less 141 (41%)
Some college 215 (35%) Some college 54 (30%) Some college 15 (27%) Some college 146 (38%)
College graduate 321 (32%) College graduate 91 (22%) College graduate 32 (31%) College graduate 198 (36%)
Subtype 0.006 Rai Stage 0.27 IPS 0.027 IPI <0.0001
 CLL/SLL 275 (27%)  0 123 (24%)  1 17 (12%)  0-1 221 (29%)
 HL 127 (33%)  1 108 (29%)  2 746 (26%)  2 188 (44%)
 NHL 867 (37%)  2-4 26 (39%)  3 37 (38%)  3 137 (48%)
 4-6 27 (52%)  4-5 80 (61%)
Aggressiveness <0.0001
 Indolent NHL 355 (25%) Ann Arbor Stage 0.056 Ann Arbor Stage 0.002
 Aggressive NHL 532 (45%)  I-II 72 (26%)  I-II 285 (30%)
 CLL/SLL 275 (27%)  III-IV 54 (43%)  III-IV 575 (41%)
Subtype <0.0001
 FL 241 (26%)
 DLBCL 295 (46%)
 MCL 57 (44%)
 Post FL 128 (22%)
 T-Cell 68 (43%)
 Other NHL 78 (62%)

CLL/SLL: Chronic lymphocytic leukemia/Small lymphocytic lymphoma; HL: Hodgkin lymphoma; NHL: non-Hodgkin lymphoma; IPS: International Prognostic Score; IPI: International Prognostic Index; FL: Follicular lymphoma; DLBCL: Diffuse large B-cell lymphoma; MCL: Mantle cell lymphoma; T-Cell: T-cell lymphoma